Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pediatrix Medical (MD) Equity Average: 2009-2024

Historic Equity Average for Pediatrix Medical (MD) over the last 16 years, with FY2024 value amounting to $807.0 million.

  • Pediatrix Medical's Equity Average rose 1983.85% to $862.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $862.2 million, marking a year-over-year increase of 1983.85%. This contributed to the annual value of $807.0 million for FY2024, which is 727.84% down from last year.
  • Pediatrix Medical's Equity Average amounted to $807.0 million in FY2024, which was down 727.84% from $870.3 million recorded in FY2023.
  • In the past 5 years, Pediatrix Medical's Equity Average ranged from a high of $1.1 billion in FY2020 and a low of $807.0 million during FY2024
  • Moreover, its 5-year median value for Equity Average was $870.3 million (2023), whereas its average is $903.4 million.
  • As far as peak fluctuations go, Pediatrix Medical's Equity Average crashed by 5101.87% in 2020, and later surged by 875.18% in 2022.
  • Over the past 5 years, Pediatrix Medical's Equity Average (Annual) stood at $1.1 billion in 2020, then dropped by 26.81% to $822.2 million in 2021, then rose by 8.75% to $894.2 million in 2022, then dropped by 2.66% to $870.3 million in 2023, then dropped by 7.28% to $807.0 million in 2024.
  • Its last three reported values are $807.0 million in FY2024, $870.3 million for FY2023, and $894.2 million during FY2022.